For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C
The Journal of Thoracic and Cardiovascular Surgery · 2025
DOI: 10.1016/j.jtcvs.2024.06.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Jessica M Ruck und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Md. Hauptthemen laut MEDLINE: Heart Transplantation, Waiting Lists, Hepatitis C, Tissue Donors. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
BACKGROUND: Despite excellent outcomes of heart transplants from hepatitis C virus (HCV)-positive donors (D+), many candidates are not listed to even consider HCV D+ offers. METHODS: Using the Scientific Registry of Transplant Recipients, we identified adult (age ≥18 years) heart transplant candidates prevalent on the waitlist between 2018 and March 2023. We compared the likelihood of waitlist mortality or heart transplant by candidate willingness to consider HCV D+ offers using competing risk regression. RESULTS: We identified 19,415 heart transplant candidates, 68.9% of whom were willing to consider HCV D+ offers. Candidates willing to consider HCV D+ offers had a 37% lower risk of waitlist mortality (subhazard ratio [SHR], 0.63; 95% confidence interval [CI], 0.56-0.70; P < .001) than candidates not willing to consider HCV D+ offers, after adjustment for covariates and center-level clustering. Over the same period, heart transplant candidates willing to consider HCV D+ offers had a 21% higher likelihood of receiving a transplant (SHR, 1.21; 95% CI, 1.7-1.26; P < .001). As a result, among candidates willing to consider HCV D+ offers, 74.9% received a transplant and 6.1% died/deteriorated after 3 years, compared to 68.3% and 9.1%, respectively, of candidates not willing to consider HCV D+ offers. Lower waitlist mortality also was observed on subgroup analyses of candidates on temporary and durable mechanical circulatory support. CONCLUSIONS: Willingness to consider HCV D+ heart offers was associated with a 37% lower risk of waitlist mortality and a 21% higher likelihood of receiving a transplant. We urge providers to encourage candidates to list as being willing to consider offers from donors with hepatitis C to optimize their waitlist outcomes and access to transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Md.
- Division of Infectious Disease, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
- Department of Surgery, New York University Grossman School of Medicine and Langone Health, New York, NY; Department of Population Health, New York University Grossman School of Medicine and Langone Health, New York, NY.
- Department of Surgery, New York University Grossman School of Medicine and Langone Health, New York, NY; Department of Population Health, New York University Grossman School of Medicine and Langone Health, New York, NY;…
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: Akilic2@jhmi.edu.
Förderung
- NIA NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute on Aging
Zitieren
APA
Ruck, J. M., Rodriguez, E., Zhou, A. L., Durand, C. M., Massie, A. B., Segev, D. L., Polanco, A., Bush, E. L., & Kilic, A. (2025). For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.06.025
Vancouver
Ruck JM, Rodriguez E, Zhou AL, Durand CM, Massie AB, Segev DL, et al. For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2024.06.025
BibTeX
@article{Ruck2025,
author = {Ruck, Jessica M and Rodriguez, Emily and Zhou, Alice L and Durand, Christine M and Massie, Allan B and Segev, Dorry L and Polanco, Antonio and Bush, Errol L and Kilic, Ahmet},
title = {For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2025},
doi = {10.1016/j.jtcvs.2024.06.025}
}
EUVIMED